Polymeric Nanoparticle Polypeptide Complex Stabilization
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for delivering molecules to mammals face challenges such as degradation and limited bioavailability due to enzymatic activity, particularly in treating conditions characterized by the absence or disruption of normal enzymatic function, like Krabbe disease, where molecules like polypeptides and enzymes have short half-lives and struggle to cross the blood-brain barrier.
Innovation Solution
The use of polymeric nanoparticles, specifically assembled from COOH-PEG-PLA, methoxy-PEG-PLA, or maleimide-PEG-PLA polymers, to conjugate and stabilize enzymes like galactocerebrosidase, increasing their half-life and bioavailability by forming complexes through covalent or non-covalent bonds, thereby reducing aggregation and enhancing delivery across the blood-brain barrier.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If polypeptides are administered to treat enzymatic disorders, then therapeutic enzyme levels can be increased, but the polypeptides are degraded by proteases and have short half-lives
Solution Approach 1:
A nanoparticle carrier system acts as an intermediary between the administered polypeptide and the proteolytic enzymes in the body. The nanoparticle protects the polypeptide from degradation while facilitating its delivery to target tissues, thereby extending half-life and maintaining therapeutic efficacy.
Solution Approach 2:
The patent modifies the physical and chemical parameters of the polypeptide by conjugating it to a nanoparticle carrier. This changes the polypeptide's susceptibility to protease degradation and its pharmacokinetic properties, resulting in extended circulation half-life and improved therapeutic performance.
2Reliability
If polypeptides are administered to treat lysosomal storage disorders, then enzyme replacement can occur, but the polypeptides struggle to cross the blood-brain barrier
Solution Approach 1:
The nanoparticle carrier serves as a mediator that facilitates the transport of polypeptides across the blood-brain barrier. The nanoparticle's specific properties enable it to interact with and traverse the barrier, delivering the therapeutic enzyme to the central nervous system where it would otherwise be inaccessible.
3Duration of action of stationary object
If enzymes are conjugated to polymeric nanoparticles, then half-life and stability are increased, but the complexity of the delivery system increases
Solution Approach 1:
The patent creates a composite material system combining a polymeric nanoparticle carrier with a therapeutic polypeptide. This composite structure integrates the stability and protective properties of the polymer with the therapeutic function of the enzyme, achieving extended half-life while maintaining a relatively simple overall system architecture.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The nanoparticle-conjugated enzymes maintain at least 85-95% enzymatic activity, exhibit increased stability, and improve delivery to the central nervous system, prolonging bioavailability and therapeutic efficacy, as demonstrated by prolonged enzyme activity and reduced aggregation, with potential for treating lysosomal storage disorders and other enzymatic disorders.
Implementation Method 1
The polypeptide can be attached to a polymeric nanoparticle via a covalent bond
Implementation Method 2
The polypeptide can be attached to a polymeric nanoparticle via a non-covalent bond
Implementation Method 3
reducing aggregation and enhancing delivery across the blood-brain barrier
Data Source
AI summary
This document relates to methods and materials involved in delivering molecules to a mammal. For example, methods and materials for using nanoparticles to increase the half-life and the bioavailability of molecules administered to a mammal are provided.